May 26, 2016 5:48 AM ET


Company Overview of Permeon Biologics, Inc.

Key Executives for Permeon Biologics, Inc.

NameBoard RelationshipsTitleAge
Katherine S. Bowdish Ph.D.20 RelationshipsPresident, Chief Scientific Officer and Director58
David R. Liu Ph.D.43 RelationshipsScientific Advisory Board Chairman, Board Observer and Founding Scientist--
John Ripple 15 RelationshipsChief Executive Officer of Permeon Biologics--
Steven S. Gillis M.D., Ph.D.138 RelationshipsBoard Observer61

Permeon Biologics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Katherine S. Bowdish Ph.D. 20 RelationshipsPermeon Biologics, Inc.58
David R. Liu Ph.D. 43 RelationshipsEditas Medicine Inc.--
Douglas Cole M.D. 19 RelationshipsPermeon Biologics, Inc.--
Keith L. Crandell MBA 69 RelationshipsArch Venture Partners, L.P.55
Noubar B. Afeyan Ph.D. 137 RelationshipsSeres Therapeutics, Inc.52
View All Board Members

Permeon Biologics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Advisory Board Ph.D.David R. Liu43 Relationships8 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Total Value of Options
Compensation as of Fiscal Year
Permeon Biologics, Inc. CEO Compensation
Industry Average


Inivata Appoints Clive Morris as Chief Medical Officer
May 25, 2016 6:00 AM ET
Gilead Sciences, Inc. Announces Executive Changes
May 24, 2016 8:30 PM ET
Premier Biomedical, Inc. Appoints James Frincke as Chief Technical Officer
May 24, 2016 6:19 PM ET
Swedish Orphan Biovitrum AB Announces Board Appointments
May 24, 2016 5:00 PM ET
ARIAD Pharmaceuticals, Inc. Appoints Jennifer L. Herron as Executive Vice President and Chief Commercial Officer, Effective May 31, 2016
May 24, 2016 1:25 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Permeon Biologics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at